Preliminary Program: Friday, June 3 CSS = Clinical Science Symposium T
ED = Education Session
MTP = Meet the Professor Session (ticketed)
Primary Track
1:00 PM
The most current program is available on am.asco.org. Sessions are listed under primary track only.
T
EXT ED = Extended Education Session
CPO = Clinical Problems in Oncology Session (ticketed)
2:00
3:00
4:00
5:00
Special Sessions Breast Cancer
T
MTP: Complex Decision Making in Clinical Practice: Interpreting HER2 Results
CSS: Breast Cancer—HER2/ER
Cancer Prev, Genetics, & Epi Care Delivery & Practice Mgmt
EXT ED: Genetics and Genomic Testing in Oncology Care EXT ED: Practicing in the Age of Value-Based Clinical Pathways
CNS Tumors
EXT ED: Multidisciplinary Management of Brain Metastases
Dev Therapeutics & Transl Res
ED: Biomarkers, BloodBased Testing, and the Heterogeneous Tumor
ED: Pharmacokinetics, Dynamics, and Genomics in the Era of Immunotherapy and Small Molecules
T
MTP: Prescribing and Managing Immunotherapy
T
CPO: Testicular Cancer: A Multidisciplinary CaseBased Discussion
GI (Colorectal) Cancer ED: HER2, VEGFR, and Beyond: Genomic Profiling of GI (Noncolorectal) Upper Gastrointestinal Tract Cancer Cancers and the Future of Personalized Treatment GU (Nonprostate) Cancer
T
MTP: Systemic and Surgical Considerations in Upper Tract Transitional Cell Carcinoma
ED: Contemporary Active Surveillance for Prostate Cancer: Do We Need Better Imaging and Molecular Testing? ED: Intraperitoneal Chemotherapy for Ovarian Cancer: Trials and Tribulations
ED: Oligometastatic Disease in Prostate Cancer: Treating the Patient or the Scan?
GU (Prostate) Cancer Gynecologic Cancer
ED: Localized Pancreatic Cancer: Multidisciplinary Management With Incorporation of ASCO Guidelines
EXT ED: Global Oncology Clinical Science Symposium: HPV-Associated Malignancies
Head & Neck Cancer ED: NICE or Not? Evaluating Global Strategies for Sustainable Cancer Care
HSR & Quality Hematologic Malignancies— Leukemia, MDS, & Allotransplant Hematologic Malignancies— Lymphoma & CLL Hematologic Malignancies— Plasma Cell Dyscrasia
EXT ED: Immunotherapeutic Approaches to Treating Hematologic Malignancies
Oral Abstract Session: Hematologic Malignancies—Plasma Cell Dyscrasia
Lung Cancer Melanoma/Skin Cancers Patient & Survivor Care Pediatric Oncology
Professional Development
ED: New and Improved? Use of White Blood Cell Growth Factors in Oncology Practice ED: The State of the Art in Neuroblastoma: From Biology to Survivorship
EXT ED: Heart to Heart: How to Protect the Heart During Cancer Therapy Oral Abstract Session: Pediatric Oncology I
EXT ED: Practical Tips for Academic, Private, and Industry Career Tracks: Negotiating Contracts and Education Debt Management ED: Special Session for Program Directors and Key Clinical Faculty T EXT ED: Maintenance of Certification and Lifelong Learning Workshop EXT ED: Grant Writing Workshop EXT ED: On the Shoulders of Giants: Cooperative Groups and Clinical Trial Design—Past, Present, and Future
Sarcoma Tumor Biology
REGISTER NOW AT AM.ASCO.ORG
13
Preliminary Program: Saturday, June 4 CSS = Clinical Science Symposium Primary Track
ED = Education Session
7:30 AM
8:00
9:00
CSS: Special Clinical Science Symposium #1
Special Sessions
EXT ED = Extended Education Session 10:00
11:00
Opening Session With Fellows of the American Society of Clinical Oncology, Guest Speaker’s Address, Presidential Address, ASCO Humanitarian Award, and David A. Karnofsky Memorial Award and Lecture
Breast Cancer Cancer Prev, Genetics, & Epi
ED: Controversies in Genetic Evaluation
Care Delivery & Practice Mgmt
ED: The Oncology Care Model: The Man Behind the Curtain
CNS Tumors
T
MTP: Treatment of Medulloblastoma: The Devil Is in the Details
Dev Therapeutics & Transl Res GI (Colorectal) Cancer
Poster Session: Gastrointestinal (Colorectal) Cancer
GI (Noncolorectal) Cancer
Poster Session: Gastrointestinal (Noncolorectal) Cancer
GU (Nonprostate) Cancer GU (Prostate) Cancer
ED: Precision Medicine in Advanced Prostate Cancer: Understanding Genomics, Androgen Receptor Splice Variants, and Imaging Biomarkers
Gynecologic Cancer
ED: Divide and Conquer: Epithelial Gynecologic Cancers Beyond BRCA
Head & Neck Cancer
ED: Best of the Rest: Top Abstracts on Head and Neck Cancer From 2015-2016 Oncology Meetings
HSR & Quality
ED: Using Social Media, Wearables, and Electronic Medical Records to Improve Quality of Cancer Care
Hematologic Malignancies— Leukemia, MDS, & Allotransplant Hematologic Malignancies— Lymphoma & CLL
ED: Chemoimmunotherapy Versus Targeted Treatment in Chronic Lymphocytic Leukemia: When, How Long, How Much, and in Which Combination?
Hematologic Malignancies— Plasma Cell Dyscrasia
ED: Defining and Redefining Myeloma Poster Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers Poster Session: Lung Cancer—Non-Small Cell Metastatic ED: Lung Cancer Screening and Prevention CPO: Real-World Issues Using Immunotherapy and Targeted T Therapies in Melanoma EXT ED: Individualizing Care for Older Adults Across the Cancer Care Continuum: Emerging Evidence and Collective Wisdom ED: Controversies in Germ-Line Genetic Testing and Disclosure in Pediatric Oncology
Lung Cancer
Melanoma/Skin Cancers Patient & Survivor Care Pediatric Oncology
Professional Development
ED: How to Navigate the Annual Meeting (Fellows and Junior Faculty Only)
Sarcoma Tumor Biology
14
#ASCO16 PROGRAM ANNOUNCEMENT
12:00 PM
The most current program is available on am.asco.org. Sessions are listed under primary track only. T
MTP = Meet the Professor Session (ticketed) 1:00
T
2:00 ASCO/American Association for Cancer Research (AACR) Joint Session: The Next Frontier of Genomics in the Clinic and Clinical Trials
CPO = Clinical Problems in Oncology Session (ticketed)
3:00
4:00
5:00
AWARD: Gianni Bonadonna Award and Lecture
Oral Abstract Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy ED: Evolving Recommendations on Prostate Cancer Screening ED: Death With Dignity or PhysicianAssisted Suicide? A Thoughtful Discussion
ED: MACRA Town Hall: Effects on Your Medicare Reimbursement Poster Discussion Session: Central Nervous System Tumors
Poster Session: Central Nervous System Tumors
ED: Clinical Trial Eligibility Criteria: Tradition Versus Reality ED: Molecular Oncology Tumor Board
Oral Abstract Session: Developmental Therapeutics—Immunotherapy Poster Discussion Session: Gastrointestinal (Colorectal) Cancer MTP: Locally Advanced T Esophageal and Gastric Cancer: When Neoadjuvant Therapy Fails ED: Elderly Patients With Bladder Cancer: Perspectives From a Surgeon, Medical, and Radiation Oncologist
T
MTP: Imaging in Rectal Cancer Poster Discussion Session: Gastrointestinal (Noncolorectal) Cancer
ED: Biliary Tract Cancer: The New and the Old
Poster Discussion Session: Genitourinary (Prostate) Cancer
Poster Session: Genitourinary (Prostate) Cancer ED: Symptom Management for the Patient with Gynecologic Cancer
T
Poster Session: Head and Neck Cancer T
MTP: Cervical Cancer Screening and Prevention in Low-Resource Countries Poster Discussion Session: Head and Neck Cancer
CPO: Challenging Cases in the Management of Head and Neck Cancer
Poster Session: Health Services Research and Quality of Care
Poster Discussion Session: Health Services Research and Quality of Care
ED: Financial Toxicity: Risks, Outcomes, and Solutions
ED: Removing Barriers to Clinical Trial Participation and Presentation of Clinical Trial Participation Awards
ED: Progress in Myeloproliferative Neoplasms: Are We Ready?
Oral Abstract Session: Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
ED: Current Management Concepts: Primary Central Nervous System Lymphoma, Natural Killer T-Cell Lymphoma Nasal Type, Posttransplant Lymphoproliferative Disorder T
Poster Discussion Session: Lung Cancer—Non-Small Cell LocalRegional/Small Cell/Other Thoracic Cancers
Poster Discussion Session: Lung Cancer—Non-Small Cell Metastatic Poster Discussion Session: Melanoma/Skin Cancers
Poster Session: Melanoma/Skin Cancers
ED: Differences in Approaches to Hodgkin Lymphoma Across the Adolescent and Young Adult Divide
T
CPO: Practical Tips to Engage Your Trainees, Advanced-Practice Providers, and Patients
CPO: Rare Plasma Cell Dyscrasia: Amyloid, Monoclonal Gammopathy of Renal Significance, and Waldenstrom Macroglobulinemia
ED: Cancer Treatment as an Accelerated Aging Process ED: Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors ED: Women in Oncology: A Roundtable Discussion on Professional Development
ED: Expanding the Clinically Actionable Cancer Genome
REGISTER NOW AT AM.ASCO.ORG
15
Preliminary Program: Sunday, June 5 CSS = Clinical Science Symposium
ED = Education Session
Primary Track
7:30 AM
8:00
Special Sessions
Highlights of the Day Session I
EXT ED = Extended Education Session
9:00
10:00
11:00
12:00 PM
CSS: Special Clinical Science Symposium #2
Poster Session: Breast Cancer—HER2/ER Breast Cancer Cancer Prev, Genetics, & Epi
Poster Discussion Session: Breast Cancer—HER2/ER
Poster Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy T
MTP: Cancer Screening in Survivors
CSS: Cancer Prevention ED: Quality and Value: Measuring and Utilizing Both in Your Practice ED: The Future of Immunotherapy in Glioblastoma Poster Discussion Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics
Care Delivery & Practice Mgmt CNS Tumors
Dev Therapeutics & Transl Res
GI (Colorectal) Cancer GI (Noncolorectal) Cancer GU (Nonprostate) Cancer GU (Prostate) Cancer
Oral Abstract Session: Central Nervous System Tumors Poster Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics Poster Session: Developmental Therapeutics—Immunotherapy Oral Abstract Session: Gastrointestinal (Colorectal) Cancer
Oral Abstract Session: Genitourinary (Nonprostate) Cancer T
CPO: Tumor Board on Systemic Therapies for Metastatic Prostate Cancer: Induction, Maintenance, and Sequencing
T
Gynecologic Cancer Head & Neck Cancer
Oral Abstract Session: Gynecologic Cancer Oral Abstract Session: Head and Neck Cancer ED: Opportunities for Collective Decision Making in Clinical Practice
HSR & Quality Hematologic Malignancies— Leukemia, MDS, & Allotransplant Hematologic Malignancies— Lymphoma & CLL Hematologic Malignancies— Plasma Cell Dyscrasia Lung Cancer Melanoma/Skin Cancers
MTP: Radium 223 in the Management of Castration-Resistant Prostate Cancer
ED: Molecularly and Phenotypically Defined Subtypes of Acute Lymphoblastic Leukemia: Implications for Management
T
MTP: Management of Acute Lymphoblastic Leukemia in Adolescent and Young Adult Patients Oral Abstract Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Oral Abstract Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers CPO: Now That We Have T Immunotherapy, What Do We Do? ED: Curing High-Risk Melanoma: Are We There Yet?
Patient & Survivor Care
Oral Abstract Session: Patient and Survivor Care
ED: Cancer Survivorship: Is Every Patient’s Journey the Same? (Includes Presentation of Partners in Progress Award)
Pediatric Oncology
Oral Abstract Session: Pediatric Oncology II
AWARD: Pediatric Oncology Award and Lecture
Professional Development
ED: Training Program Directors’ Breakfast
Sarcoma
Oral Abstract Session: Sarcoma
Tumor Biology
ED: Tumor Heterogeneity and Therapeutic Resistance
16
#ASCO16 PROGRAM ANNOUNCEMENT
CPO: The Role of Chemotherapy in the Neoadjuvant, Adjuvant, and Metastatic Setting T for Patients With Soft Tissue Sarcoma: Where Do We Stand in 2016? ED: Molecular Diagnostics in Cancer
The most current program is available on am.asco.org. Sessions are listed under primary track only. T
MTP = Meet the Professor Session (ticketed) 1:00
2:00
T
CPO = Clinical Problems in Oncology Session (ticketed)
3:00
Plenary Session Including the Science of Oncology Award and Lecture The Plenary Session includes abstract presentations of the top practice-changing science, with commentary from expert discussants.
4:00 Post-Plenary Discussion Session: Abstract 1
5:00 Post-Plenary Discussion Session: Abstract 2
Post-Plenary Discussion Session: Abstract 3
Post-Plenary Discussion Session: Abstract 4
Poster Discussion Session: Breast Cancer—TripleNegative/Cytotoxics/Local Therapy
ED: Optimizing Team-Based Oncology Care: Building the Village
Poster Discussion Session: Developmental Therapeutics— Immunotherapy ED: Potentially Resectable Metastatic Colorectal Cancer: A Multidisciplinary Discussion
ED: Practical Challenges in Endometrial Cancer MTP: Current State of Functional T Organ Preservation in Head and Neck Cancer ED: Defining and Measuring Quality
ED: Consolidation and Maintenance: Moving Beyond Autotransplant
ED: Treatment of Lung Cancer in Medically Compromised Patients
ED: Optimizing Palliative and End-ofLife Care: Evidence-Based Practice Improvement
T
CPO: Case Studies From the Frontline: Building Leadership Skills to Resolve Conflicts
ED: Is There a Future for Immunotherapy in Sarcoma?
REGISTER NOW AT AM.ASCO.ORG
17
Preliminary Program: Monday, June 6 CSS = Clinical Science Symposium Primary Track Special Sessions
ED = Education Session
7:30 AM
8:00
EXT ED = Extended Education Session
9:00
10:00
Highlights of the Day Session II
ASCO/European CanCer Organisation (ECCO) Joint Session: Value-Based Care
ASCO Annual Business Meeting ED: Updates and Controversies in HER2Positive Breast Cancer
ED: Breast Cancer Survivorship: Strategies for Optimal Care
Cancer Prev, Genetics, & Epi
Poster Session: Cancer Prevention, Hereditary Genetics, and Epidemiology ED: Refining Breast Cancer Risk Assessment: Additional Genes, Additional Screening T
12:00 PM ASCO Book Club
Breast Cancer
Care Delivery & Practice Mgmt
11:00
CSS: Special Clinical Science Symposium #3
ED: Access to Cancer Therapeutics in Low- and Middle-Income Countries ED: Treatment of LowGrade Gliomas in the Era of Genomic Medicine
MTP: The Contract: Employed Physicians and Shifting Incentives
CNS Tumors Dev Therapeutics & Transl Res
Oral Abstract Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics
GI (Colorectal) Cancer
CSS: Gastrointestinal (Colorectal) Cancer
GI (Noncolorectal) Cancer
Oral Abstract Session: Gastrointestinal (Noncolorectal) Cancer ED: Renal Cell Carcinoma: Systemic Treatment, Evolving TKIs, and Immuno-Oncology
GU (Nonprostate) Cancer GU (Prostate) Cancer
Oral Abstract Session: Genitourinary (Prostate) Cancer
Gynecologic Cancer
ED: Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer
Head & Neck Cancer
HSR & Quality
CSS: Gynecologic Cancer
ED: Integrating Immune Checkpoint Inhibitors and Targeted Agents with Surgery and Radiotherapy for Patients with Head and Neck Cancer MTP: Inside the Minds of Patients: Incorporating Patient-Reported T Outcomes Into Clinical Trials and Drug Approvals
CSS: Head and Neck Cancer
Oral Abstract Session: Health Services Research and Quality of Care
ED: Evolving Therapies in Acute Myeloid Leukemia: Progress at Last?
ED: Why Are Myelodysplastic Syndromes So Difficult to Cure?
Hematologic Malignancies— Lymphoma & CLL
Poster Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Hematologic Malignancies— Plasma Cell Dyscrasia
Poster Session: Hematologic Malignancies-Plasma Cell Dyscrasia
Lung Cancer
T
MTP: Stereotactic Body Radiation Therapy or Surgery for Early-Stage Non-Small Cell Lung Cancer
Melanoma/Skin Cancers CSS: Geriatric Oncology
Pediatric Oncology
Poster Session: Pediatric Oncology
Sarcoma
Poster Session: Sarcoma
Tumor Biology
ED: What’s Next in Cancer Immunotherapy
#ASCO16 PROGRAM ANNOUNCEMENT
MTP: Diffuse Large B-Cell Lymphoma: When to Refer Patients for Radiation Therapy
ED: Metastatic Melanoma: Making the Right Treatment Choices
MTP: Melanoma Immunotherapy: Where Do We Go From Here?
AWARD: B.J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology T
ED: Curing Burnout in Oncology: Mindful Self-Compassion, Communication, and Practice
Professional Development
T
Oral Abstract Session: Lung Cancer—Non-Small Cell Metastatic
T
Patient & Survivor Care
18
Poster Discussion Session: Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Poster Session: Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Hematologic Malignancies— Leukemia, MDS, & Allotransplant
CSS: Tumor Biology
MTP: Advancing the Field of Supportive Care in Pediatric Oncology
The most current program is available on am.asco.org. Sessions are listed under primary track only. T
MTP = Meet the Professor Session (ticketed) 1:00
T
2:00
CPO = Clinical Problems in Oncology Session (ticketed)
3:00
4:00
5:00
ASCO/Radiological Society of North America (RSNA) Joint Session: Breast Cancer Imaging ED: Targeted Therapies in Hormone Receptor–Positive Breast Cancer
Oral Abstract Session: Breast Cancer—HER2/ER Poster Discussion Session: Cancer Prevention, Hereditary Genetics, and Epidemiology
AWARD: ASCO/American Cancer Society Award and Lecture
ED: Integrating Patient-Reported Outcomes Into Real-Life Medical Decisions CSS: Central Nervous System Tumors ED: Biomarker Tests for Molecularly Targeted Therapies: Implications and Recommendations for Practicing Oncologists and Investigators
ED: Immunotherapy: Beyond Checkpoint Inhibitors
ED: Designing Clinical Trials to Achieve Breakthrough Results in Upper Gastrointestinal Malignancies Poster Session: Genitourinary (Nonprostate) Cancer
Poster Discussion Session: Genitourinary (Nonprostate) Cancer
ED: Cytoreductive Nephrectomy in Renal Cell Carcinoma: A Debate
Poster Session: Gynecologic Cancer ED: Neoadjuvant Chemotherapy: Location, Location, Location
Poster Discussion Session: Gynecologic Cancer ED: Multimodality Management of Locoregionally Recurrent or Second Primary Head and Neck Cancer ED: Expanded Access and the Right to Try: Navigating the Intersection of Drug Development and Patient Access to Investigational Agents
Poster Discussion Session: Hematologic Malignancies— Lymphoma and Chronic Lymphocytic Leukemia
T
T
Poster Discussion Session: Hematologic Malignancies—Plasma Cell Dyscrasia
MTP: How I Treat High-Risk Multiple Myeloma
MTP: Initial Therapy for Older Patients With Chronic Lymphocytic Leukemia ED: PET-Directed Strategies in Lymphoma ED: Multiple Myeloma: Are We Ready for Personalized Therapy?
ED: Local Therapies in the Management of Oligometastatic and Metastatic Non-Small Cell Lung Cancer
CSS: Lung Cancer—Non-Small Cell Metastatic
ED: Clinical Conundrums in Melanoma Therapy
Oral Abstract Session: Melanoma/Skin Cancers Poster Session: Patient and Survivor Care ED: Rehabilitation of Patients and Survivors: Seizing the Opportunity
Poster Discussion Session: Patient and Survivor Care
Poster Discussion Session: Pediatric Oncology T
MTP: The Peer-Review Process and Writing an Outstanding Manuscript T
MTP: GISTs and Beyond: New Targets and Novel Therapies Poster Discussion Session: Sarcoma
Poster Session: Tumor Biology T
MTP: The Liquid Biopsy: Breaking out the Key Components
ED: Economic and Regulatory Implications in Drug Development for Sarcoma and Rare Cancers: The Identification of Value and Quality Poster Discussion Session: Tumor Biology
REGISTER NOW AT AM.ASCO.ORG
19
Preliminary Program: Tuesday, June 7 CSS = Clinical Science Symposium T
ED = Education Session
MTP = Meet the Professor Session (ticketed)
Primary Track
7:30 AM
The most current program is available on am.asco.org. Sessions are listed under primary track only.
8:00
T
EXT ED = Extended Education Session
CPO = Clinical Problems in Oncology Session (ticketed)
9:00
10:00
11:00
12:00 PM
Special Sessions Highlights of the Day Session III Breast Cancer Cancer Prev, Genetics, & Epi Care Delivery & Practice Mgmt
ED: Treatment of Premenopausal Women With Endocrine-Sensitive Breast Cancer Oral Abstract Session: Cancer Prevention, Hereditary Genetics, and Epidemiology
ED: Triple-Negative Breast Cancer: Is Change on the Horizon?
ED: Less Is More: A Multidisciplinary Conversation on Treatment Options
CNS Tumors Dev Therapeutics & Transl Res
ED: Biosimilars: Here and Now ED: Debating Current Controversies in Medical Management of Metastatic Colorectal Cancer
GI (Colorectal) Cancer GI (Noncolorectal) Cancer GU (Nonprostate) Cancer GU (Prostate) Cancer Gynecologic Cancer
ED: Questions on Treatment of Locally Advanced Rectal Cancer
CSS: GU (Nonprostate) Cancer
Head & Neck Cancer HSR & Quality Hematologic Malignancies— Leukemia, MDS, & Allotransplant Hematologic Malignancies— Lymphoma & CLL Hematologic Malignancies— Plasma Cell Dyscrasia
CSS: Lymphoma CSS: Hematologic Malignancies—Plasma Cell Dyscrasia ED: Small Cell Lung Cancer: On the Move (Again?)
Lung Cancer Melanoma/Skin Cancers Patient & Survivor Care Pediatric Oncology Professional Development Sarcoma
ED: Noncytotoxic Approaches to the Treatment of Metastatic Soft Tissue Sarcoma
Tumor Biology
Oral Abstract Session: Tumor Biology
20
#ASCO16 PROGRAM ANNOUNCEMENT
ED: Immunotherapy: Beyond Anti-PD-1 and Anti-PDL1 Therapies